Persistent Asset Partners »

Kalvista Pharmaceuticals shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $181k 9.0k 20.13

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
State Street Corporation
Vestal Point Capital
Vanguard Capital Management
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals